Vascular function in adults with cyanotic congenital heart disease

[1]  Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification , 2020, Definitions.

[2]  S. Grajek,et al.  Arterial stiffness and arterial function in adult cyanotic patients with congenital heart disease. , 2017, Journal of cardiology.

[3]  T. Engstrøm,et al.  Cyanotic congenital heart disease and atherosclerosis , 2017, Heart.

[4]  E. Schwedhelm,et al.  Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans , 2016, PloS one.

[5]  B. Dahlbäck,et al.  Protein unfolding allows use of commercial antibodies in an apolipoprotein M sandwich ELISA[S] , 2015, Journal of Lipid Research.

[6]  C. Christoffersen,et al.  Apolipoprotein M in lipid metabolism and cardiometabolic diseases , 2015, Current opinion in lipidology.

[7]  S. Graham,et al.  Widespread endotheliopathy in adults with cyanotic congenital heart disease , 2014, Cardiology in the Young.

[8]  R. Draijer,et al.  Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. , 2013, International journal of cardiology.

[9]  J. Nofer,et al.  Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice , 2013, PloS one.

[10]  Shane B Wing,et al.  Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier , 2012, The Journal of Biological Chemistry.

[11]  E. Vicaut,et al.  Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) , 2012, Cerebrovascular Diseases.

[12]  F. Kardelen,et al.  Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease , 2012, Annals of pediatric cardiology.

[13]  Erling Falk,et al.  Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. , 2012, JACC. Cardiovascular imaging.

[14]  B. Dahlbäck,et al.  Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M , 2011, Proceedings of the National Academy of Sciences.

[15]  B. Mulder,et al.  Atherosclerosis in patients with cyanotic congenital heart disease. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[16]  H. Bøtker,et al.  Preserved Flow-Mediated Dilation in Adults with Cyanotic Congenital Heart Disease , 2009, Pediatric Cardiology.

[17]  K. Dimopoulos,et al.  Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. , 2009, The American journal of cardiology.

[18]  T. Michel,et al.  S1P and eNOS regulation. , 2008, Biochimica et biophysica acta.

[19]  M. Rubens,et al.  Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. , 2007, Journal of the American College of Cardiology.

[20]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[21]  S. Strandgaard,et al.  Flow-Associated Dilatory Capacity of the Brachial Artery Is Intact in Early Autosomal Dominant Polycystic Kidney Disease , 2006, American Journal of Nephrology.

[22]  H. Ogawa,et al.  Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. , 2006, Internal medicine.

[23]  H. Brunner-La Rocca,et al.  Systemic Endothelial Dysfunction in Adults With Cyanotic Congenital Heart Disease , 2005, Circulation.

[24]  J. Child,et al.  Cyanotic congenital heart disease and coronary artery atherogenesis. , 2005, The American journal of cardiology.

[25]  A. Zeiher,et al.  Endothelial Function: Cardiac Events , 2005, Circulation.

[26]  V R Newey,et al.  A rapid and reproducible on line automated technique to determine endothelial function , 2002, Heart.

[27]  K. Claffey,et al.  Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.

[28]  D. Celermajer,et al.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.

[29]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[30]  R. Wells.  Syndromes of hyperviscosity. , 1970, The New England journal of medicine.